Page last updated: 2024-11-03

rimantadine and Infections, Coronavirus

rimantadine has been researched along with Infections, Coronavirus in 2 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Research Excerpts

ExcerptRelevanceReference
"The International Society for Influenza and other Respiratory Virus Diseases (isirv) held its 4th Antiviral Group Conference at the University of Texas on 2-4 June, 2015."1.43Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses. ( Fry, AM; McKimm-Breschkin, JL, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Iftikhar, H1
Ali, HN1
Farooq, S1
Naveed, H1
Shahzad-Ul-Hussan, S1
McKimm-Breschkin, JL1
Fry, AM1

Other Studies

2 other studies available for rimantadine and Infections, Coronavirus

ArticleYear
Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.
    Computers in biology and medicine, 2020, Volume: 122

    Topics: Amides; Betacoronavirus; Carbamates; Catalytic Domain; Computer Simulation; Coronavirus Infections;

2020
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    Antiviral research, 2016, Volume: 129

    Topics: Amantadine; Antibody-Dependent Enhancement; Antiviral Agents; Coronavirus Infections; Drug Resistanc

2016